AU Patent

AU2020355000A1 — Compositions and methods for modulating apolipoprotein B (APOB) gene expression

Assigned to Omega Therapeutics Inc · Expires 2022-03-17 · 4y expired

What this patent protects

The present invention provides agents and compositions for modulating expression (

USPTO Abstract

The present invention provides agents and compositions for modulating expression (

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: AU2020355000A1
Jurisdiction: AU
Classification: —
Expires: 2022-03-17
Drug substance claim: No
Drug product claim: No
Assignee: Omega Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.